Renub Research’s reports incorporate various aspects of the healthcare industry

According to the latest report by Renub Research, titled " Continuous Glucose Monitoring (CGM) Market, Users, Reimbursement Policy, Global Analysis, CGM Components Market, Diabetes (Type1 & 2) Population, & Forecast " captures a detailed analysis of the CGM Market. The numbers of diabetic patients are increasing year on year. Therefore the market of monitoring devices is also growing, according to Renub Research analysis, the Global CGM Market will be US$ 5.6 Billion by the year 2025. CGM is an essential device that offers real-time information on blood glucose levels and helps find a detailed blood glucose level pattern within 24 hours (288 reading). CGM gives Real-time reading every five minutes. Besides, since patients do not need to poke their finger, CGM is better than glucose-meter. For patients with daily hypoglycemia and hyperglycemia and glycemic targets, CGM is recommended. Continuous glucose monitoring (CGM) offers dynamic information about the path of glu

Renub Research report titled " Ophthalmic Devices Market Global Forecast by Application, Products, Region, Companies " The field of ophthalmology includes medical devices for different purposes, including diagnosis, vision treatment, and surgery. Developing groundbreaking technologies and growing technology implementation in ophthalmology has paved the way for customers to provide functional and affordable solutions for various eye-related disorders such as vitreoretinal disorders, refractory disorders and cataract disorders. Vision treatment services contribute to the most important portion of the overall demand for ophthalmic devices. These products include contact lenses, spectacles, and methods for lens cleaning and disinfecting both eyewear and surgical instruments. Worldwide growth in the geriatric population is one of the prime factors for the upward trend in the ophthalmic devices industry. It is known that the aged are more likely to develop eye-related conditions, s

According to the latest report by Renub Research, titled " Molecular Diagnostics Market Share & Global Forecast, By Application, Technology, End User, Regions, Companies" The molecular diagnostic is a combination of various techniques, which are used to determine the biological markers in the field of proteome and genome. Through molecular diagnostics genetic code of any individual and analysis of their cells is known as how they express genes as proteins by molecular biology to testing in medical science. Technologies which are used in molecular diagnostics are PCR, Transcription-Mediated Amplification (TMA), Hybridiazation (In-situ Hybridiazation & FISH), DNA Sequencing & NGS, and Microarray. With the use of molecular diagnostics monitoring individual patients for disease, detecting risks and selecting best therapy which suits the patient are possible. Molecular diagnostics is also helpful in personalized medicine by detailed analysis of specific patients and d

According to the latest report by Renub Research, titled "Diabetes Drug Market Global & Forecast By Disease, Oral Therapy, Injection, Insulin, Regions, Company"  Diabetes drugs are used to control blood glucose level in Type 1 and Type 2 diabetic patients. These medicines are given to treat diabetes mellitus by various drugs like Insulin, Sulphonylureas, and Metformin. Around the world market for diabetes, drugs are growing continuously at a much higher rate. According to Renub Research analysis, the Global Diabetes Drug Market is forecasted to be US$ 78.10 Billion by the end of the year 2026. The major growth factors for diabetes drug market are growing prevalence of diabetes in most of the countries, growth in ageing population, adoption of a sedentary lifestyle, the growing adoption of diabetes drugs in the regions of the Asia Pacific and European Union, such as China, Japan, India, United Kingdom, Spain, Germany, France. The growths of new drugs like Dapagliflozin,